Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
10.06
+0.16 (1.62%)
Jun 30, 2026, 2:04 PM EDT - Market open

Ocular Therapeutix Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Ocular Therapeutix stock has a consensus rating of "Strong Buy" and an average price target of $27.09. The average 1-year stock price forecast is 169.28% higher than the current stock price, while the lowest is $18 (+78.93%) and the highest is $34 (+237.97%).

Price Target: $27.09 (+169.28%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$18$27.09$28$34
Change+78.93%+169.28%+178.33%+237.97%

Analyst Ratings

The average analyst rating for Ocular Therapeutix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy887777
Buy444444
Hold000000
Sell000000
Strong Sell000000
Total121211111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Chardan Capital
Chardan Capital
Buy
Maintains
$21$23
BuyMaintains$21$23+128.63%Jun 25, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$27
BuyReiterates$27+168.39%Jun 22, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$21$25
BuyReiterates$21$25+148.51%Jun 22, 2026
Needham
Needham
Buy
Maintains
$18
BuyMaintains$18+78.93%Jun 18, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$31
BuyMaintains$31+208.15%Jun 18, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
51.91M
from 51.95M
Decreased by -0.08%
Revenue Next Year
120.39M
from 51.91M
Increased by 131.91%
EPS This Year
-1.55
from -1.42
EPS Next Year
-1.54
from -1.55
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
43.52M51.49M58.44M63.72M51.95M51.91M
Revenue Growth
150.08%18.32%13.50%9.03%-18.47%-0.08%
Gross Profit
-10.97M-6.51M-7.89M-69.54M-151.72M46.37M
Gross Margin
-25.20%-12.64%-13.51%-109.13%-292.04%89.33%
Operating Income
-78.04M-78.65M-82.38M-160.88M-270.02M-374.11M
Net Income
-6.55M-71.04M-80.74M-193.51M-265.94M-361.74M
EPS
-----1.42-1.55
Free Cash Flow
-38.07M-33.30M-49.44M-79.78M-128.28M-279.00M
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High56.3M
Avg51.9M
Low45.4M

Revenue Growth

Revenue Growth202620272028
High
8.4%
Avg
-0.1%
Low
-12.6%

EPS Forecast

EPS202620272028
High-1.27
Avg-1.55
Low-1.71

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-